Benjamin Edwards’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Benjamin Edwards's NVS Position: Q3 2026 in Review
Benjamin Edwards reduced its Novartis (NVS) stake by 28% in Q3 2026, selling an estimated $254K and leaving 4,303 shares worth $613K. The position accounts for 0.01% of the portfolio, ranked #988.
Benjamin Edwards first reported a position in NVS in Q1 2019 and has held it in 31 quarters since. The position peaked at $5.24M in Q3 2024. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Benjamin Edwards held 4,303 shares of Novartis worth $613K as of Q3 2026.
- Benjamin Edwards sold 1,676 Novartis shares in Q3 2026, an estimated $254K.
- Novartis made up 0.01% of Benjamin Edwards's portfolio in Q3 2026, its #988 holding.
- Benjamin Edwards first reported a position in Novartis in Q1 2019 and has held it in 31 quarters since.
- Benjamin Edwards's Novartis position peaked at $5.24M in Q3 2024.
- 1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.